Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baumgartner J. D., Heumann D., Gerain J., Weinbreck P., Grau G. E., Glauser M. P. Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies. J Exp Med. 1990 Mar 1;171(3):889–896. doi: 10.1084/jem.171.3.889. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baumgartner J. D. Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal. Infect Dis Clin North Am. 1991 Dec;5(4):915–927. [PubMed] [Google Scholar]
- Bone R. C. Gram-negative sepsis: a dilemma of modern medicine. Clin Microbiol Rev. 1993 Jan;6(1):57–68. doi: 10.1128/cmr.6.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hurley J. C. Antibiotic-induced release of endotoxin: a reappraisal. Clin Infect Dis. 1992 Nov;15(5):840–854. doi: 10.1093/clind/15.5.840. [DOI] [PubMed] [Google Scholar]
- Hurley J. C., Louis W. J., Tosolini F. A., Carlin J. B. Antibiotic-induced release of endotoxin in chronically bacteriuric patients. Antimicrob Agents Chemother. 1991 Nov;35(11):2388–2394. doi: 10.1128/aac.35.11.2388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hurley J. C. Reappraisal of the role of endotoxin in the sepsis syndrome. Lancet. 1993 May 1;341(8853):1133–1135. doi: 10.1016/0140-6736(93)93139-r. [DOI] [PubMed] [Google Scholar]
- Raetz C. R., Ulevitch R. J., Wright S. D., Sibley C. H., Ding A., Nathan C. F. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 1991 Sep;5(12):2652–2660. doi: 10.1096/fasebj.5.12.1916089. [DOI] [PubMed] [Google Scholar]
- Sprung C. L., Peduzzi P. N., Shatney C. H., Schein R. M., Wilson M. F., Sheagren J. N., Hinshaw L. B. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med. 1990 Aug;18(8):801–806. doi: 10.1097/00003246-199008000-00001. [DOI] [PubMed] [Google Scholar]
- Warren H. S., Amato S. F., Fitting C., Black K. M., Loiselle P. M., Pasternack M. S., Cavaillon J. M. Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J Exp Med. 1993 Jan 1;177(1):89–97. doi: 10.1084/jem.177.1.89. [DOI] [PMC free article] [PubMed] [Google Scholar]